CLSD Clearside Biomedical, Inc.

Nasdaq clearsidebio.com


$ 3.71 $ 0.05 (1.37 %)    

Friday, 17-Oct-2025 11:07:15 EDT
QQQ $ 601.46 $ 3.85 (0.64 %)
DIA $ 460.54 $ 1.18 (0.26 %)
SPY $ 661.65 $ 2.18 (0.33 %)
TLT $ 91.10 $ -0.13 (-0.14 %)
GLD $ 386.65 $ -10.55 (-2.66 %)
$ 3.705
$ 3.66
$ 3.70 x 200
$ 3.84 x 2,555
$ 3.71 - $ 3.76
$ 3.32 - $ 19.80
63,807
na
19.39M
$ 1.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-12-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-12-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-14-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-11-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-15-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 03-13-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 03-14-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-16-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-11-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-12-2016 06-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...

 clearside-to-showcase-versatility-of-scs-microinjector-and-cls-ax-programs-for-retinal-diseases-at-euretina-2025

- Presentations Highlight the Versatility of Clearside's SCS Microinjector® Platform for the Treatment of Multiple Retinal ...

 deal-dispatch-del-taco-tanks-tylenol-maker-aches-for-change-joyebells-burns-the-pie

This week's M&A news includes strategic pivots and stumbles galore, with updates from WK Kellogg, Matador Restaurant an...

 chardan-capital-downgrades-clearside-biomedical-to-neutral

Chardan Capital analyst Daniil Gataulin downgrades Clearside Biomedical (NASDAQ:CLSD) from Buy to Neutral.

 hc-wainwright--co-downgrades-clearside-biomedical-to-neutral-maintains-price-target-to-5

HC Wainwright & Co. analyst Yi Chen downgrades Clearside Biomedical (NASDAQ:CLSD) from Buy to Neutral and maintains the ...

 needham-downgrades-clearside-biomedical-to-hold-announces-3-price-target

Needham analyst Serge Belanger downgrades Clearside Biomedical (NASDAQ:CLSD) from Buy to Hold and announces $3 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION